that will support continuous growth momentum in demand for medical devices in Thailand. In 2019, the Company has improved and increased the sales team to increase sales efficiency in distributor of
share. 8. Sources of Financing The Company will finance this Transaction with the capital received from the capital increase of the Company of Baht 9.90 million. As of 31 December 2019, the Company has
finance this Transaction with the capital received from the capital increase of the Company of Baht 9.90 million. As of 31 December 2019, the Company has cash and cash equivalent as well as current
be expected to increase a lot in the future Since it is an area in the Eastern Economic Corridor area. There is a high rate of growth in the industrial sector. The management sees the opportunity to
, an increase of 121 million baht or 9% y-y. The Company reported net profit attributed to owners of the parent of 1,184 million baht, an increase of 128 million baht or 12% y-y and 17% q-q, and earning
; (6) asset value of mutual fund; (7) issuance of investment units and an increase or reduction of registered capital whereby there shall be a requirement specifying that the management company shall
ENDED DECEMBER 31, 2017 1. Operating performance as compar ison analysis between those in the year 2017 and 2016 in consolidated financial statement. Description 2017 2016 Increase (Decrease) Amount
appraisal price of 17,080,583.92 baht (exclude vat)) 7) Terms of payment 20% Down Payment and 80% After installation and Commissioning Funding source, the Company will using proceeds from the capital increase
, the Company will using proceeds from the capital increase to the private placement of the Extraordinary General Meeting of Shareholders No.1/2018 on January 18, 2018. 8) Opinion of the Board of